The Columbia-Stanford Consortium on Medical Innovation, established in 2002 with generous funding from the Merck Company Foundation, is a multidisciplinary research and training program. The overall objectives of the Consortium are three-fold:

To train a new generation of policy-oriented researchers that transcend their disciplinary training to think critically about the inherently interdisciplinary and complex dynamics of medical innovation

To conduct research projects that carefully analyze how historical, economic, institutional, and regulatory factors affect the rate and direction of innovation in medicine, as well as suggest promising areas for future policy change

To disseminate these results to a wide range of important players in the health care arena.

The Consortium is led by faculty in Medicine, Public Health, Public Policy, Business, Economics, Sociology and Education at Columbia and Stanford University.